News
SalvaRx Group plc - Investment in Rift Biotherapeutics
RNS Number: 8786 Z SalvaRx Group plc 20 March 2017 SalvaRx Group PLC. SalvaRx Group PLC is pleased to announce that its subsidiary, SalvaRx Limited, has entered into an agreement to invest in Rift Biotherapeutics Inc., a private, Delaware- domiciled biotechnology company focused on the development of antibodies for use in oncology.. Subject to Rift achieving...
RNS Number: 8786 Z SalvaRx Group plc 20 March 2017 SalvaRx Group PLC. SalvaRx Group PLC is pleased to announce that its subsidiary, SalvaRx Limited, has entered into an agreement to invest in Rift Biotherapeutics Inc., a private, Delaware- domiciled biotechnology company focused on the development of antibodies for use in oncology.. Subject to Rift achieving...